Verizon to cut 15,000 jobs amid growing competition pressures - WSJ
Investing.com -- Eckert & Ziegler shares climbed 5% on Thursday after the company released its third-quarter results showing solid growth that was broadly in line with analyst estimates at the group level.
The company’s Isotopes division rebounded during the quarter despite ongoing project-related delays linked to a cyberattack.
The segment outperformed expectations, with revenue approximately 9% higher and EBIT about 19% above estimates. The rebound was partially attributed to easier comparative figures from the previous year.
Meanwhile, the Medical segment continued to show strong performance with 18% growth in the third quarter, though results came in slightly below expectations with sales 2% under forecasts and EBIT 4% below analyst projections.
Eckert & Ziegler specifically noted ongoing strength in generators and Contract Development and Manufacturing Organization (CDMO) activities within this segment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.